Overview

Prevention and Treatment of Common Hyperglycemia in Surgery

Status:
ENROLLING_BY_INVITATION
Trial end date:
2026-04-01
Target enrollment:
Participant gender:
Summary
The PATCH pilot trial aims to establish feasibility and determine the sample size of a future, large-scale, multi-site RCT, as well as reinforce the long-standing known safety profile of glucose, insulin, and potassium (GIK) and explore the physiologic response. We hypothesize that the use of GIK in non-diabetic patients undergoing abdominal surgery, will reduce rates of morbidity \& death compared to standard of care treatment. In brief, primary outcomes of interest include estimation of the standard deviation (to derive a sample size estimation) and the ability to recruit target population, assessment of patient compliance/burden, and assessment of provider compliance/burden (feasibility).
Phase:
PHASE4
Details
Lead Sponsor:
University of Washington
Treatments:
Glucose
Insulin
Potassium